177 related articles for article (PubMed ID: 33742279)
21. The Initial Area Under the Curve Derived from Dynamic Contrast-Enhanced MRI Improves Prognosis Prediction in Glioblastoma with Unmethylated
Choi YS; Ahn SS; Lee HJ; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK
AJNR Am J Neuroradiol; 2017 Aug; 38(8):1528-1535. PubMed ID: 28642265
[TBL] [Abstract][Full Text] [Related]
22. Distinct displacements of the optic radiation based on tumor location revealed using preoperative diffusion tensor imaging.
Faust K; Vajkoczy P
J Neurosurg; 2016 May; 124(5):1343-52. PubMed ID: 26430843
[TBL] [Abstract][Full Text] [Related]
23. Upfront boost Gamma Knife "leading-edge" radiosurgery to FLAIR MRI-defined tumor migration pathways in 174 patients with glioblastoma multiforme: a 15-year assessment of a novel therapy.
Duma CM; Kim BS; Chen PV; Plunkett ME; Mackintosh R; Mathews MS; Casserly RM; Mendez GA; Furman DJ; Smith G; Oh N; Caraway CA; Sanathara AR; Dillman RO; Riley AS; Weiland D; Stemler L; Cannell R; Abrams DA; Smith A; Owen CM; Eisenberg B; Brant-Zawadzki M
J Neurosurg; 2016 Dec; 125(Suppl 1):40-49. PubMed ID: 27903197
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of subventricular zone involvement in relation to tumor volumes defined by fused MRI and O-(2-[
Harat M; Małkowski B; Roszkowski K
Radiat Oncol; 2019 Mar; 14(1):37. PubMed ID: 30832691
[TBL] [Abstract][Full Text] [Related]
25. Radiomic Analysis Reveals Prognostic Information in T1-Weighted Baseline Magnetic Resonance Imaging in Patients With Glioblastoma.
Ingrisch M; Schneider MJ; Nörenberg D; Negrao de Figueiredo G; Maier-Hein K; Suchorska B; Schüller U; Albert N; Brückmann H; Reiser M; Tonn JC; Ertl-Wagner B
Invest Radiol; 2017 Jun; 52(6):360-366. PubMed ID: 28079702
[TBL] [Abstract][Full Text] [Related]
26. Temporal Glioblastoma Mimicking Basal Ganglia Invasion: Distinguishing Removable and Unremovable Tumors.
Shibahara I; Hanihara M; Miyasaka K; Sato S; Hide T; Kumabe T
World Neurosurg; 2019 Oct; 130():e213-e221. PubMed ID: 31252080
[TBL] [Abstract][Full Text] [Related]
27. Rapid Early Tumor Progression is Prognostic in Glioblastoma Patients.
Palmer JD; Bhamidipati D; Shukla G; Sharma D; Glass J; Kim L; Evans JJ; Judy K; Farrell C; Andrews DW; Wang ZW; Peiper SC; Werner-Wasik M; Shi W
Am J Clin Oncol; 2019 May; 42(5):481-486. PubMed ID: 30973372
[TBL] [Abstract][Full Text] [Related]
28. Olfactory function as an independent prognostic factor in glioblastoma.
Kebir S; Hattingen E; Niessen M; Rauschenbach L; Fimmers R; Hummel T; Schäfer N; Lazaridis L; Kleinschnitz C; Herrlinger U; Scheffler B; Glas M
Neurology; 2020 Feb; 94(5):e529-e537. PubMed ID: 31831598
[TBL] [Abstract][Full Text] [Related]
29. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials.
Simpson JR; Horton J; Scott C; Curran WJ; Rubin P; Fischbach J; Isaacson S; Rotman M; Asbell SO; Nelson JS
Int J Radiat Oncol Biol Phys; 1993 May; 26(2):239-44. PubMed ID: 8387988
[TBL] [Abstract][Full Text] [Related]
30. Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials.
Ellingson BM; Harris RJ; Woodworth DC; Leu K; Zaw O; Mason WP; Sahebjam S; Abrey LE; Aftab DT; Schwab GM; Hessel C; Lai A; Nghiemphu PL; Pope WB; Wen PY; Cloughesy TF
Neuro Oncol; 2017 Jan; 19(1):89-98. PubMed ID: 27580889
[TBL] [Abstract][Full Text] [Related]
31. [The phenomenon of long-term survival in glioblastoma patients. Part I: the role of clinical and demographic factors and an IDH1 mutation (R 132 H)].
Goryaynov SA; Gol'dberg MF; Golanov AV; Zolotova SV; Shishkina LV; Ryzhova MV; Pitskhelauri DI; Zhukov VY; Usachev DY; Belyaev AY; Kondrashov AV; Shurkhay VA; Potapov AA
Zh Vopr Neirokhir Im N N Burdenko; 2017; 81(3):5-16. PubMed ID: 28665384
[TBL] [Abstract][Full Text] [Related]
32. Negative prognostic impact of epidermal growth factor receptor copy number gain in young adults with isocitrate dehydrogenase wild-type glioblastoma.
Hoffman DI; Abdullah KG; McCoskey M; Binder ZA; O'Rourke DM; Desai AS; Nasrallah MP; Bigdeli A; Morrissette JJD; Brem S; Bagley SJ
J Neurooncol; 2019 Nov; 145(2):321-328. PubMed ID: 31542863
[TBL] [Abstract][Full Text] [Related]
33. Adverse prognosis and distinct progression patterns after concurrent chemoradiotherapy for glioblastoma with synchronous subventricular zone and corpus callosum invasion.
Liang TH; Kuo SH; Wang CW; Chen WY; Hsu CY; Lai SF; Tseng HM; You SL; Chen CM; Tseng WY
Radiother Oncol; 2016 Jan; 118(1):16-23. PubMed ID: 26678342
[TBL] [Abstract][Full Text] [Related]
34. The preliminary radiogenomics association between MR perfusion imaging parameters and genomic biomarkers, and their predictive performance of overall survival in patients with glioblastoma.
Liu X; Mangla R; Tian W; Qiu X; Li D; Walter KA; Ekholm S; Johnson MD
J Neurooncol; 2017 Dec; 135(3):553-560. PubMed ID: 28889246
[TBL] [Abstract][Full Text] [Related]
35. Differentiating between glioblastomas with and without isocitrate dehydrogenase gene mutation by findings on conventional magnetic resonance images.
Shimizu T; Matsushima S; Fukasawa N; Akasaki Y; Mori R; Ojiri H
J Clin Neurosci; 2020 Jun; 76():140-144. PubMed ID: 32291242
[TBL] [Abstract][Full Text] [Related]
36. Correlation Between Tumor Location and Clinical Properties of Glioblastomas in Frontal and Temporal Lobes.
Li HY; Sun CR; He M; Yin LC; Du HG; Zhang JM
World Neurosurg; 2018 Apr; 112():e407-e414. PubMed ID: 29355809
[TBL] [Abstract][Full Text] [Related]
37. Does age matter? - A MRI study on peritumoral edema in newly diagnosed primary glioblastoma.
Seidel C; Dörner N; Osswald M; Wick A; Platten M; Bendszus M; Wick W
BMC Cancer; 2011 Apr; 11():127. PubMed ID: 21481277
[TBL] [Abstract][Full Text] [Related]
38. [Factor analysis of cerebrospinal fluid spread in glioblastoma].
Huang J; Li MX; Ma ML; Ren XH; Cui Y; Lin S
Zhonghua Wai Ke Za Zhi; 2020 Jun; 58(6):469-474. PubMed ID: 32498488
[No Abstract] [Full Text] [Related]
39. Prognostic Prediction Based on Dynamic Contrast-Enhanced MRI and Dynamic Susceptibility Contrast-Enhanced MRI Parameters from Non-Enhancing, T2-High-Signal-Intensity Lesions in Patients with Glioblastoma.
Jo SW; Choi SH; Lee EJ; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH
Korean J Radiol; 2021 Aug; 22(8):1369-1378. PubMed ID: 33987994
[TBL] [Abstract][Full Text] [Related]
40. The Prognostic Role of Peritumoral Edema in Patients with Newly Diagnosed Glioblastoma: A Retrospective Analysis.
Zhang M; Ye F; Su M; Cui M; Chen H; Ma X
J Clin Neurosci; 2021 Jul; 89():249-257. PubMed ID: 34119276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
